Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Short term Debt (2016 - 2023)

Bio-Techne has reported Short term Debt over the past 8 years, most recently at $1.8 million for Q3 2023.

  • For Q3 2023, Short term Debt fell 76.35% year-over-year to $1.8 million; the TTM value through Sep 2023 reached $1.8 million, down 76.35%, while the annual FY2023 figure was $3.5 million, 72.0% down from the prior year.
  • Short term Debt for Q3 2023 was $1.8 million at Bio-Techne, down from $3.5 million in the prior quarter.
  • Over five years, Short term Debt peaked at $12.5 million in Q1 2019 and troughed at $1.8 million in Q3 2023.
  • A 5-year average of $9.4 million and a median of $12.5 million in 2019 define the central range for Short term Debt.
  • Biggest five-year swings in Short term Debt: soared 257.14% in 2019 and later crashed 76.35% in 2023.
  • Year by year, Short term Debt stood at $9.9 million in 2019, then rose by 26.63% to $12.5 million in 2020, then changed by 0.0% to $12.5 million in 2021, then plummeted by 40.8% to $7.4 million in 2022, then crashed by 76.35% to $1.8 million in 2023.
  • Business Quant data shows Short term Debt for TECH at $1.8 million in Q3 2023, $3.5 million in Q2 2023, and $5.2 million in Q1 2023.